Strand Releases Enterprise Server Edition to Avadis-NGS, Establishes Reads-to-Reporting Solution for Clinical Genomics

NASHVILLE, Tennessee and BANGALORE, India, April 1, 2014 /PRNewswire/ --

At the ACMG Annual Clinical Genetics meeting this week, Strand Life Sciences announced the release of the Avadis-NGS Server Edition, an enterprise solution to their widely adopted Next-Generation Sequencing analytics platform.  The Avadis-NGS Server Edition was designed to facilitate collaborative analysis through central storage of data and analysis results.  "As more and more people in a lab are using NGS, there is a need to optimize for sharing, scalability and efficiency," said Dr. Vamsi Veeramachaneni, VP-Software Development at Strand.  "The Avadis-NGS Server Edition provides a central repository for data and pipelines, so it's easy to add computational resources to the server at any time to handle larger sample volumes."

The Avadis-NGS Server Edition works on all hardware platforms and is configurable to accommodate the needs of labs of different sizes and focus areas - from research to clinical diagnostics.  A web-based interface for system administration enables the administrator to manage tasks, schedule backups, and monitor system usage.

In addition to the introduction of the Server Edition, Avadis-NGS now supports the streamlined integration into StrandOmics, Strand's clinical interpretation and reporting platform, providing an end-to-end solution to support the needs of a clinical genomics lab.  "We started using the integrated Avadis-NGS - StrandOmics pipeline and our clinical reporting throughput improved dramatically," said Dr. Preveen Ramamoorthy, Laboratory Director, Strand Center for Genomics and Personalized Medicine and Head of Clinical Diagnostics, Strand Life Sciences.  "We can easily move from the analysis pipelines that we've created in Avadis-NGS into StrandOmics which provides all the scientific and medical information our medical geneticists need to classify patient variants and make an accurate diagnosis.  StrandOmics provides all the supporting literature evidence and automatically formats the references in the report, leading to increased productivity from our medical genetics team."

StrandOmics is entering the second phase of its Early Access Program and is recruiting new participants. Details http://www.strandomics.com

About Strand Life Sciences 

Strand was founded in 2000 by faculty from the prestigious Indian Institute of Science. Over 2000 research laboratories worldwide are licensees of Strand's genomics software products. With a recent investment by Biomark-Capital, Strand now operates on over 25,000-square-feet of state-of-the-art next-generation sequencing laboratories in Bangalore and has established Strand Centers for Genomics and Personalized Medicine, serving over 50 hospitals across India with growing presence in the U.S. Website: http://www.strandls.com

SOURCE Strand Life Sciences